|
Monographs
|
Realizing Near-Normoglycemia - a CME Monograph |
|
Your must be a member to download monographs pdf files.
Click here to login or sign up for a free membership.
|
FACULTY
Lawrence Blonde, MD, FACP, FACE
Director, Ochsner Clinical Research Unit, Section of Endocrinology, Diabetes and Metabolic Diseases, Associate Residency Program Director, Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, Louisana
Jaime A. Davidson, MD, FACP, FACE
Endocrinologist, Endocrine & Diabetes Associates of Texas and Medical City Dallas Hospital, Clinical Associate Professor of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas
William V. Tamborlane, MD
Professor and Section Chief of Pediatric Endocrinology and Diabetes, Department of Pediatrics and the General Clinical Research Center , Yale University School of Medicine, New Haven, Connecticut
STATEMENT OF NEED
Diabetes mellitus is an evolving epidemic in the United States and around the world. More than 18 million people in the United States have diabetes, 5.2 million have not yet been diagnosed, and 1.3 million are newly diagnosed each year.1 Moreover, 41 million people have prediabetes (impaired fasting glucose or impaired glucose tolerance)1 and are likely to progress to type 2 diabetes without intervention. While there is evidence supporting the importance of achieving good glycemic control, many patients with type 2 diabetes are failing to achieve the glycemic goals recommended by the American Diabetes Association (ADA), the American College of Endocrinology (AACE), and other organizations. Health care professionals and patients must work together to implement strategies to better manage diabetes and to achieve the recommended glycemic goals. These strategies include not only lifestyle changes but also early intensive treatment with oral antidiabetic drugs and insulin in a ”treat-to-target” approach to achieve and maintain glycemic goals, as well as tools for patient self-management.
PROGRAM GOAL
Diabetes control in the United States has worsened in the last decade. Adherence of patients to lifestyle and pharmacologic treatment is often suboptimal, and many physicians have not yet adopted a treat-to-target approach to diabetes care. This monograph addresses the barriers to successful achievement of glycemic goals in difficult-to-treat patients with diabetes. This group includes adult patients who fail to achieve recommended glycemic targets, and children and adolescents whose treatment regimens are complicated by age, metabolic factors, and issues of compliance. This program will also discuss hypoglycemia, which has been inconsistently defined and interpreted in a number of recent diabetes studies.
EDUCATIONAL OBJECTIVES
After completing this educational activity, participants should be able to:
- Discuss the barriers to successful achievement of glycemic goals in difficult-to-treat patients with type 2 diabetes.
- Describe the current AACE glycemic targets.
- Discuss the symptoms, consequences, and management of hypoglycemia.
- Delineate the benefits of early intensive therapy.
- Explain patient barriers to insulin therapy, including the fear of injection and weight gain, and concern over convenience.
INTENDED AUDIENCE
This activity is intended for endocrinologists, internal medicine specialists, primary care providers, and other health care professionals involved in the treatment of patients with type 2 diabetes.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Excerpta Medica, Inc. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CME CREDIT STATEMENT
The EOCM designates this educational activity for a maximum of 1.5 category 1 credits toward the American Medical Association (AMA) Physician's Recognition Award (PRA). Each physician should claim only those credits that he/she actually spends in the educational activity.
FINANCIAL SUPPORT
This CME activity is supported by an educational grant from The sanofi-aventis Group.
|
|
|
